Citation Impact
Citing Papers
V Diretrizes Brasileiras de Hipertensão Arterial
2007 Standout
Identification of a Retinal Aldosterone System and the Protective Effects of Mineralocorticoid Receptor Antagonism on Retinal Vascular Pathology
2008
Salt-Sensitive Blood Pressure in Mice With Increased Expression of Aldosterone Synthase
2007 StandoutNobel
Disturbed Homeostasis in Sodium-Restricted Mice Heterozygous and Homozygous for Aldosterone Synthase Gene Disruption
2006 StandoutNobel
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
2008 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Epithelialization in Wound Healing: A Comprehensive Review
2014 Standout
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
2005 Standout
The −344T>C promoter variant of the gene for aldosterone synthase (CYP11B2) is not associated with cardiovascular risk in a prospective study of UK healthy men
2004
Mice lacking osteopontin exhibit increased left ventricular dilation and reduced fibrosis after aldosterone infusion
2004
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 Standout
Cushing's syndrome
2015 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
The pathogenesis of cardiac fibrosis
2013 Standout
Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction
2006 Standout
Evidence for Abnormal Left Ventricular Structure and Function in Normotensive Individuals with Familial Hyperaldosteronism Type I
2005
A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease
2007 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Effect of MR Blockade on Collagen Formation and Cardiovascular Disease with a Specific Emphasis on Heart Failure
2005
Diabetic Retinopathy
2012 Standout
Non-adrenal synthesis of aldosterone: A reality check
2011
International Union of Pharmacology. LXV. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Glucocorticoid, Mineralocorticoid, Progesterone, and Androgen Receptors
2006
Pyroptosis: A new frontier in cancer
2019 Standout
Primary Hyperaldosteronism
2006
The mineralocorticoid receptor as a novel player in skin biology: beyond the renal horizon?
2009
Diagnosis of primary aldosteronism: from screening to subtype differentiation
2005
Hypertension in Cushing's syndrome
2006
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
2013 Standout
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
2005 Standout
The inflammatory response in myocardial injury, repair, and remodelling
2014 Standout
Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
2003 Standout
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Aldosterone and end-organ damage
2005
Expert consensus document on arterial stiffness: methodological issues and clinical applications
2006 Standout
Cardiovascular Effects of Aldosterone and Post–Acute Myocardial Infarction Pathophysiology
2006
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
2006 Standout
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
POOR NUTRITIONAL STATUS AND INFLAMMATION: Novel Approaches in an Integrated Therapy of Inflammatory‐Associated Wasting in End‐Stage Renal Disease
2004
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Diabetic Cardiomyopathy
2018 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
De Novo Synthesis of γ,γ‐Disubstituted Butyrolactones through a Visible Light Photocatalytic Arylation–Lactonization Sequence
2014
A Nuclear Receptor Atlas: Macrophage Activation
2005
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
Pleiotropic AT1 Receptor Signaling Pathways Mediating Physiological and Pathogenic Actions of Angiotensin II
2005
Mechanisms of Diabetic Complications
2013 Standout
Eplerenone
2003
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Extrapineal melatonin: sources, regulation, and potential functions
2014 Standout
Mineralocorticoid Receptor Blockade Improves Coronary Microvascular Function in Individuals With Type 2 Diabetes
2014
Effects of the Selective Aldosterone Blocker Eplerenone Versus the Calcium Antagonist Amlodipine in Systolic Hypertension
2003
Visible‐Light Photocatalysis: Does It Make a Difference in Organic Synthesis?
2018 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Aldosterone and end-organ damage
2007
Macrophages, Inflammation, and Insulin Resistance
2010 Standout
Increased Diagnosis of Primary Aldosteronism, Including Surgically Correctable Forms, in Centers from Five Continents
2004
Works of Ellen McMahon being referenced
Recent studies with eplerenone, a novel selective aldosterone receptor antagonist
2001
Molecular Mechanisms of Mineralocorticoid Receptor Antagonism by Eplerenone
2005
Selective Aldosterone Blockade Prevents Angiotensin II/Salt-Induced Vascular Inflammation in the Rat Heart
2002